Gut microbiota and microbiota-derived metabolites in cardiovascular diseases
Abstract. Cardiovascular diseases, including heart failure, coronary artery disease, atherosclerosis, aneurysm, thrombosis, and hypertension, are a great economic burden and threat to human health and are the major cause of death worldwide. Recently, researchers have begun to appreciate the role of...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2023-10-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000002206 |
| _version_ | 1797646888471625728 |
|---|---|
| author | Xiaofeng Chen Hua Zhang Sichong Ren Yangnan Ding Naznin Sultana Remex Md. Shenuarin Bhuiyan Jiahua Qu Xiaoqiang Tang Ningning Wang Peifang Wei |
| author_facet | Xiaofeng Chen Hua Zhang Sichong Ren Yangnan Ding Naznin Sultana Remex Md. Shenuarin Bhuiyan Jiahua Qu Xiaoqiang Tang Ningning Wang Peifang Wei |
| author_sort | Xiaofeng Chen |
| collection | DOAJ |
| description | Abstract. Cardiovascular diseases, including heart failure, coronary artery disease, atherosclerosis, aneurysm, thrombosis, and hypertension, are a great economic burden and threat to human health and are the major cause of death worldwide. Recently, researchers have begun to appreciate the role of microbial ecosystems within the human body in contributing to metabolic and cardiovascular disorders. Accumulating evidence has demonstrated that the gut microbiota is closely associated with the occurrence and development of cardiovascular diseases. The gut microbiota functions as an endocrine organ that secretes bioactive metabolites that participate in the maintenance of cardiovascular homeostasis, and their dysfunction can directly influence the progression of cardiovascular disease. This review summarizes the current literature demonstrating the role of the gut microbiota in the development of cardiovascular diseases. We also highlight the mechanism by which well-documented gut microbiota-derived metabolites, especially trimethylamine N-oxide, short-chain fatty acids, and phenylacetylglutamine, promote or inhibit the pathogenesis of cardiovascular diseases. We also discuss the therapeutic potential of altering the gut microbiota and microbiota-derived metabolites to improve or prevent cardiovascular diseases. |
| first_indexed | 2024-03-11T15:09:20Z |
| format | Article |
| id | doaj.art-f20fa4e4d1cf40478115646b6f073965 |
| institution | Directory Open Access Journal |
| issn | 0366-6999 2542-5641 |
| language | English |
| last_indexed | 2024-03-11T15:09:20Z |
| publishDate | 2023-10-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | Chinese Medical Journal |
| spelling | doaj.art-f20fa4e4d1cf40478115646b6f0739652023-10-30T03:37:50ZengWolters KluwerChinese Medical Journal0366-69992542-56412023-10-01136192269228410.1097/CM9.0000000000002206202310050-00001Gut microbiota and microbiota-derived metabolites in cardiovascular diseasesXiaofeng ChenHua ZhangSichong RenYangnan DingNaznin Sultana RemexMd. Shenuarin BhuiyanJiahua QuXiaoqiang TangNingning WangPeifang WeiAbstract. Cardiovascular diseases, including heart failure, coronary artery disease, atherosclerosis, aneurysm, thrombosis, and hypertension, are a great economic burden and threat to human health and are the major cause of death worldwide. Recently, researchers have begun to appreciate the role of microbial ecosystems within the human body in contributing to metabolic and cardiovascular disorders. Accumulating evidence has demonstrated that the gut microbiota is closely associated with the occurrence and development of cardiovascular diseases. The gut microbiota functions as an endocrine organ that secretes bioactive metabolites that participate in the maintenance of cardiovascular homeostasis, and their dysfunction can directly influence the progression of cardiovascular disease. This review summarizes the current literature demonstrating the role of the gut microbiota in the development of cardiovascular diseases. We also highlight the mechanism by which well-documented gut microbiota-derived metabolites, especially trimethylamine N-oxide, short-chain fatty acids, and phenylacetylglutamine, promote or inhibit the pathogenesis of cardiovascular diseases. We also discuss the therapeutic potential of altering the gut microbiota and microbiota-derived metabolites to improve or prevent cardiovascular diseases.http://journals.lww.com/10.1097/CM9.0000000000002206 |
| spellingShingle | Xiaofeng Chen Hua Zhang Sichong Ren Yangnan Ding Naznin Sultana Remex Md. Shenuarin Bhuiyan Jiahua Qu Xiaoqiang Tang Ningning Wang Peifang Wei Gut microbiota and microbiota-derived metabolites in cardiovascular diseases Chinese Medical Journal |
| title | Gut microbiota and microbiota-derived metabolites in cardiovascular diseases |
| title_full | Gut microbiota and microbiota-derived metabolites in cardiovascular diseases |
| title_fullStr | Gut microbiota and microbiota-derived metabolites in cardiovascular diseases |
| title_full_unstemmed | Gut microbiota and microbiota-derived metabolites in cardiovascular diseases |
| title_short | Gut microbiota and microbiota-derived metabolites in cardiovascular diseases |
| title_sort | gut microbiota and microbiota derived metabolites in cardiovascular diseases |
| url | http://journals.lww.com/10.1097/CM9.0000000000002206 |
| work_keys_str_mv | AT xiaofengchen gutmicrobiotaandmicrobiotaderivedmetabolitesincardiovasculardiseases AT huazhang gutmicrobiotaandmicrobiotaderivedmetabolitesincardiovasculardiseases AT sichongren gutmicrobiotaandmicrobiotaderivedmetabolitesincardiovasculardiseases AT yangnanding gutmicrobiotaandmicrobiotaderivedmetabolitesincardiovasculardiseases AT nazninsultanaremex gutmicrobiotaandmicrobiotaderivedmetabolitesincardiovasculardiseases AT mdshenuarinbhuiyan gutmicrobiotaandmicrobiotaderivedmetabolitesincardiovasculardiseases AT jiahuaqu gutmicrobiotaandmicrobiotaderivedmetabolitesincardiovasculardiseases AT xiaoqiangtang gutmicrobiotaandmicrobiotaderivedmetabolitesincardiovasculardiseases AT ningningwang gutmicrobiotaandmicrobiotaderivedmetabolitesincardiovasculardiseases AT peifangwei gutmicrobiotaandmicrobiotaderivedmetabolitesincardiovasculardiseases |